An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given conditional approval to enter human trials, according to Taiwan's Food and Drug Administration (FDA) on Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Politics
Ko Wen-je vows to 'not surrender,' denies guilty verdict
03/26/2026 10:49 PM -
Society
2,642 flu vaccine doses recalled over discoloration
03/26/2026 10:16 PM -
Politics
U.S. envoy calls on Taiwan legislators to pass special defense budget
03/26/2026 09:12 PM -
Politics
Clashes erupt outside Taipei court as Ko gets 17 years
03/26/2026 09:01 PM -
Business
Unemployment rate rises to 3.32% in February, ending 5-month decline
03/26/2026 07:48 PM